Basepoint Wealth’s DexCom DXCM Stock Holding History

Basepoint Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$565	Hold	9	–	–	﹤0.01%	608
2025 Q4	$597	Buy	+9	New	+$582	﹤0.01%	580

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Basepoint Wealth's DXCM Position: Q1 2026 in Review

Basepoint Wealth held its DexCom (DXCM) position steady in Q1 2026 at 9 shares worth $565. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Basepoint Wealth first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $597 in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Basepoint Wealth held 9 shares of DexCom worth $565 as of Q1 2026.
Basepoint Wealth left its DexCom share count unchanged in Q1 2026.
DexCom made up ﹤0.01% of Basepoint Wealth's portfolio in Q1 2026, its #608 holding.
Basepoint Wealth first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
Basepoint Wealth's DexCom position peaked at $597 in Q4 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.